Pfizer and BioNTech said Wednesday that initial lab tests show that the omicron variant partly escapes protection offered by the companies' two-dose regimen of their COVID-19 vaccine. However, those ...

Pfizer and BioNTech have begun a clinical trial for their Omicron-specific COVID-19 vaccine candidate, they announced in a news release on Tuesday. The study will evaluate the vaccine for safety, ...

Pfizer will begin human trials of an omicron-specific COVID-19 vaccine beginning in late January, a company spokesperson confirmed Monday to FOX TV Stations. "We already have begun work on a DNA ...

News that a Pfizer booster shot does a good job protecting against the COVID-19 Omicron variant was greeted enthusiastically by Wall Street Wednesday, as the stock markets got a big boost amid hopes ...

NEW YORK (WABC) -- Pfizer will soon request FDA authorization to expand its booster shots to 16 and 17-year-olds. It's already approved for adults age 18 and older. Pfizer vaccines were authorized for ...

Pfizer and BioNTech released more human data Friday indicating the omicron BA.5 boosters perform better than the old Covid shots. Stream NBC 5 for free, 24/7, wherever you are. People older than 55 ...